$RVTY
REVVITY, INC.

2012 Q4 Form 10-Q Financial Statement

#000144530512003461 Filed on November 06, 2012

View on sec.gov

Income Statement

Concept 2012 Q4 2012 Q3 2012 Q1
Revenue $572.9M $509.6M $539.3M
YoY Change 26.49% 6.37% 14.76%
Cost Of Revenue $311.3M $278.9M $300.8M
YoY Change 22.76% 3.33% 16.14%
Gross Profit $261.7M $230.7M $238.9M
YoY Change 31.25% 10.3% 14.5%
Gross Profit Margin 45.67% 45.28% 44.3%
Selling, General & Admin $170.8M $145.4M $204.8M
YoY Change 28.31% 5.09% 71.96%
% of Gross Profit 65.28% 63.03% 85.71%
Research & Development $33.40M $32.41M $32.00M
YoY Change 10.96% 15.61% 28.0%
% of Gross Profit 12.76% 14.05% 13.39%
Depreciation & Amortization $32.10M $32.20M $32.20M
YoY Change 14.23% 21.05% 38.2%
% of Gross Profit 12.27% 13.96% 13.48%
Operating Expenses $213.6M $177.9M $246.2M
YoY Change 30.87% 6.86% 70.74%
Operating Profit -$30.84M $49.79M -$25.86M
YoY Change -185.36% 26.3% -152.93%
Interest Expense -$11.30M $11.36M -$11.70M
YoY Change -353.99% 169.64% 216.22%
% of Operating Profit 22.82%
Other Income/Expense, Net -$600.0K -$11.87M -$1.200M
YoY Change -84.68% 177.97% -700.0%
Pretax Income -$42.74M $31.35M -$38.69M
YoY Change -232.65% -10.82% -185.25%
Income Tax -$26.50M $2.357M $44.50M
% Of Pretax Income 7.52%
Net Earnings -$15.86M $29.59M -$83.64M
YoY Change -143.3% -0.56% -128.55%
Net Earnings / Revenue -2.77% 5.81% -15.51%
Basic Earnings Per Share -$0.14 $0.30 -$0.74
Diluted Earnings Per Share -$0.14 $0.26 -$0.74
COMMON SHARES
Basic Shares Outstanding 114.8M shares 113.9M shares 113.5M shares
Diluted Shares Outstanding 115.0M shares

Balance Sheet

Concept 2012 Q4 2012 Q3 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $171.4M $171.4M $142.3M
YoY Change -30.91% -56.63% -66.13%
Cash & Equivalents $173.2M $170.8M $142.3M
Short-Term Investments
Other Short-Term Assets $95.61M $113.6M $89.86M
YoY Change 2.48% 49.51% -10.75%
Inventory $247.7M $261.4M $240.8M
Prepaid Expenses
Receivables $457.0M $394.9M $409.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $971.8M $941.0M $883.1M
YoY Change 4.51% -12.56% -18.58%
LONG-TERM ASSETS
Property, Plant & Equipment $210.5M $201.6M $174.6M
YoY Change 26.93% 20.53% 7.88%
Goodwill $2.123B $2.092B $2.094B
YoY Change 20.72% 39.17%
Intangibles $529.9M $606.1M $661.6M
YoY Change 3.44% 55.95%
Long-Term Investments $1.100M $1.100M $1.100M
YoY Change 10.0% -8.33% -21.43%
Other Assets $65.65M $47.73M $41.08M
YoY Change 90.03% 35.61% 27.96%
Total Long-Term Assets $2.930B $2.949B $2.973B
YoY Change 18.52% 17.04% 39.93%
TOTAL ASSETS
Total Short-Term Assets $971.8M $941.0M $883.1M
Total Long-Term Assets $2.930B $2.949B $2.973B
Total Assets $3.902B $3.890B $3.856B
YoY Change 14.69% 8.18% 20.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $168.9M $155.7M $173.2M
YoY Change 12.02% 4.38% 7.52%
Accrued Expenses $388.0M $402.8M $410.1M
YoY Change 10.07% -1.39% 26.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $1.772M $1.470M $0.00
YoY Change -99.51% -100.0%
Total Short-Term Liabilities $581.1M $582.3M $598.7M
YoY Change -33.66% 4.09% 16.2%
LONG-TERM LIABILITIES
Long-Term Debt $938.8M $930.9M $944.9M
YoY Change 525.88% 38.73% 122.86%
Other Long-Term Liabilities $442.0M $434.4M $469.8M
YoY Change 2.6% 6.21% 36.44%
Total Long-Term Liabilities $1.381B $1.365B $1.415B
YoY Change 137.73% 26.41% 84.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $581.1M $582.3M $598.7M
Total Long-Term Liabilities $1.381B $1.365B $1.415B
Total Liabilities $1.962B $1.948B $2.013B
YoY Change 34.68% 18.8% 56.86%
SHAREHOLDERS EQUITY
Retained Earnings $1.549B $1.572B $1.511B
YoY Change -9.08% -1.56%
Common Stock $324.6M $311.2M $277.4M
YoY Change 18.88% -18.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.940B $1.942B $1.842B
YoY Change
Total Liabilities & Shareholders Equity $3.902B $3.890B $3.856B
YoY Change 14.69% 8.18% 20.15%

Cashflow Statement

Concept 2012 Q4 2012 Q3 2012 Q1
OPERATING ACTIVITIES
Net Income -$15.86M $29.59M -$83.64M
YoY Change -143.3% -0.56% -128.55%
Depreciation, Depletion And Amortization $32.10M $32.20M $32.20M
YoY Change 14.23% 21.05% 38.2%
Cash From Operating Activities $39.60M $76.40M $82.60M
YoY Change -16.98% 47.21% 184.83%
INVESTING ACTIVITIES
Capital Expenditures -$18.00M -$6.200M -$5.600M
YoY Change 100.0% -25.3% -47.66%
Acquisitions
YoY Change
Other Investing Activities -$33.80M $1.200M -$601.9M
YoY Change -886.05% -100.53% -229.89%
Cash From Investing Activities -$51.80M -$5.100M -$607.5M
YoY Change 979.17% -97.81% -234.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 12.10M -38.60M 419.5M
YoY Change -107.07% -125.29% -236.25%
NET CHANGE
Cash From Operating Activities 39.60M 76.40M 82.60M
Cash From Investing Activities -51.80M -5.100M -607.5M
Cash From Financing Activities 12.10M -38.60M 419.5M
Net Change In Cash -100.0K 32.70M -105.4M
YoY Change -99.92% -213.54% -160.68%
FREE CASH FLOW
Cash From Operating Activities $39.60M $76.40M $82.60M
Capital Expenditures -$18.00M -$6.200M -$5.600M
Free Cash Flow $57.60M $82.60M $88.20M
YoY Change 1.59% 37.21% 122.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
155728000 USD
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
173153000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
409888000 USD
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
394937000 USD
CY2012Q3 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
6300000 USD
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
410142000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
402807000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
277386000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
299679000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-118000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-159000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-3191000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-4088000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-2169000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-2169000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
60032000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
56164000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
54086000 USD
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
58892000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164290000 USD
CY2012Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
196568000 USD
CY2011Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1467000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15352000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5101000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9427000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2655000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2114000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1792000 shares
CY2011Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2738000 shares
CY2012Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1381000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1448000 shares
CY2012Q1 us-gaap Assets
Assets
3855641000 USD
CY2012Q3 us-gaap Assets
Assets
3889971000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
883052000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
940994000 USD
CY2012Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
202000 USD
CY2012Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
202000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the &#8220;Company&#8221;), without audit, in accordance with accounting principles generally accepted in the United&#160;States of America (the &#8220;U.S.&#8221; or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company&#8217;s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC (the &#8220;</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form&#160;10-K&#8221;). The balance sheet amounts at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> in this report were derived from the Company&#8217;s audited </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements included in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. The Company adjusted the balance sheet amounts at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;">, where appropriate, to account for the measurement period adjustments related to the Caliper Life Sciences, Inc. (&#8220;Caliper&#8221;) purchase price allocation discussed in Note 2 included in this Quarterly Report on Form 10-Q. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company&#8217;s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;2, 2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. The Company has evaluated subsequent events from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> through the date of the issuance of these condensed consolidated financial statements and has determined that no material subsequent events have occurred that would affect the information presented in these condensed consolidated financial statements or would require additional disclosure. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Change in Accounting for Pension and Other Postretirement Benefits: </font><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fiscal year 2011</font><font style="font-family:inherit;font-size:10pt;"> the Company changed its method of recognizing defined benefit pension and other postretirement benefit costs. Accordingly, the financial data for all periods presented has been retrospectively adjusted to reflect the effect of these accounting changes. Actuarial gains and losses are measured annually as of fiscal year end and accordingly will be recorded in the fourth quarter, unless the Company is required to perform an interim remeasurement. This change in accounting method for pension and other postretirement benefits is described in more detail in Note 1 to the Company&#8217;s audited consolidated financial statements filed with the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;2, 2011</font><font style="font-family:inherit;font-size:10pt;"> the retrospective changes in recognizing defined benefit pension and other postretirement benefit costs increased operating income from continuing operations by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$5.9 million</font><font style="font-family:inherit;font-size:10pt;">, net income by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.3 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$3.9 million</font><font style="font-family:inherit;font-size:10pt;">, basic earnings per share by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.03</font><font style="font-family:inherit;font-size:10pt;">, diluted earnings per share by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.03</font><font style="font-family:inherit;font-size:10pt;">, and other comprehensive income (loss) by </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$1.0 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.0 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. There were no changes to the previously reported cash flows from operating, investing or financing activities for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;2, 2011</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Immaterial Restatement:</font><font style="font-family:inherit;font-size:10pt;"> As disclosed in the Company's </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K, prior to the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">fiscal year 2011</font><font style="font-family:inherit;font-size:10pt;"> annual financial statements, the Company had reported revenue and cost of revenue as single line items and had not broken out product and service revenue and related cost of revenue separately. Accordingly, the Company has restated previously reported revenue and cost of revenue for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;2, 2011</font><font style="font-family:inherit;font-size:10pt;"> to separately report product revenue, service revenue, and the related cost of product revenue and cost of service revenue.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">During the first quarter of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fiscal year 2012</font><font style="font-family:inherit;font-size:10pt;"> the Company adopted new guidance applicable to certain of its health care businesses that recognize patient service revenue at the time the services are rendered where the Company does not assess the patient's ability to pay at the time of the sale. The new guidance requires the Company to present the provision for bad debts related to such revenue as a deduction from revenue (net of contractual allowances and discounts) on the statements of operations. The effects of the adoption on the Company's condensed consolidated statements of operations resulted in a decrease to revenue and a decrease to selling, general and administrative expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">, respectively, and a decrease to revenue and a decrease to selling, general and administrative expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.9 million</font><font style="font-family:inherit;font-size:10pt;"> for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three and nine</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">October&#160;2, 2011</font><font style="font-family:inherit;font-size:10pt;">, respectively. Accordingly, the financial data for all periods presented has been retrospectively adjusted to reflect the effect of these accounting changes.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, the Company believes that such recently issued pronouncements will not have a significant impact on the Company&#8217;s condensed consolidated financial position, results of operations and cash flows or do not apply to the Company&#8217;s operations.</font></div></div>
CY2012Q3 us-gaap Business Acquisition Contingent Consideration Potential Cash Payment
BusinessAcquisitionContingentConsiderationPotentialCashPayment
21000000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
248102000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
28486000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-171984000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-1908000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
600000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4800000 USD
CY2011Q4 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
800000 USD
CY2012Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
300000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142342000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170828000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420086000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
32252000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
1976000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-9108000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-1131000 USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2012Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
CY2011Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114595000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113157000 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114595000 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113157000 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
114595000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
113157000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
90602000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50358000 USD
CY2011Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5288000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
113613000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
770317000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
840736000 USD
CY2012Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
278864000 USD
CY2011Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
253579000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
555078000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
495333000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
182179000 USD
CY2011Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
162001000 USD
CY2011Q4 us-gaap Cost Of Services
CostOfServices
91578000 USD
us-gaap Cost Of Services
CostOfServices
274984000 USD
CY2012Q3 us-gaap Cost Of Services
CostOfServices
96685000 USD
us-gaap Cost Of Services
CostOfServices
285658000 USD
CY2012Q3 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
8200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
94791000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
78718000 USD
CY2008Q2 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
8400000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
1915000 USD
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
2072000 USD
CY2011Q4 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
3813000 USD
CY2012Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
898000 USD
CY2011Q4 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-4805000 USD
CY2012Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
293000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
752000 USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-4828000 USD
CY2012Q3 us-gaap Dividends Payable Amount
DividendsPayableAmount
8000000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2011Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2011Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.80
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-670000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
568000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
10376000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 USD
CY2011Q4 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
300000 USD
CY2012Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1600000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5000000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
9303000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1767000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
9303000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1767000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
130000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-1675000 USD
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-2338000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
1085000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
20131000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-1908000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-17417000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-3771000 USD
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1206000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
21039000 USD
CY2012Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
7315000 USD
CY2011Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20909000 USD
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20298000 USD
CY2011Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1731000 USD
us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
56000000 USD
us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
68700000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
459066000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
514573000 USD
us-gaap Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
54400000 USD
us-gaap Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
63400000 USD
CY2011Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4215000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18611000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-15512000 USD
us-gaap Future Amortization Expense Year One
FutureAmortizationExpenseYearOne
22000000 USD
us-gaap Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
76900000 USD
us-gaap Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
87200000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
2092351000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
2094235000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-1884000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
28004000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
84396000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
28989000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
84633000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
31346000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
93327000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
103042000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
32219000 USD
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.75
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.75
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.25
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.74
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.74
CY2011Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.25
CY2011Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
8618000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
1163000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
6900000 USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
605000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2011Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.08
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.06
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2011Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.08
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.06
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18646000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2357000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8694000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15088000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17373000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17844000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
24447000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
41000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1354000 USD
CY2012Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
74000 USD
CY2011Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
549000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
2013425000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
1947531000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3889971000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-1123000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
661607000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
606100000 USD
us-gaap Interest Expense
InterestExpense
12578000 USD
us-gaap Interest Expense
InterestExpense
34136000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
11360000 USD
CY2011Q4 us-gaap Interest Expense
InterestExpense
4449000 USD
CY2012Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
164345000 USD
CY2012Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
153194000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
240763000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
261400000 USD
CY2012Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
82905000 USD
CY2012Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
72913000 USD
CY2012Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14150000 USD
CY2012Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14656000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
434000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3855641000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
582277000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
598682000 USD
CY2012Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1429000 USD
CY2012Q3 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1111000 USD
CY2012Q3 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
256000000 USD
CY2012Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
298000000 USD
us-gaap Line Of Credit Facility Expiration Date
LineOfCreditFacilityExpirationDate
December 16, 2016
CY2012Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
700000000 USD
CY2012Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1470000 USD
CY2012Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2012Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
930860000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
944908000 USD
CY2012Q1 us-gaap Long Term Investments
LongTermInvestments
1105000 USD
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
1144000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56274000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22292000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
21477000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-20384000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-56274000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28454000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-302417000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-334669000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-30430000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
112646000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
142349000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
151457000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
113777000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
29594000 USD
us-gaap Net Income Loss
NetIncomeLoss
91296000 USD
us-gaap Net Income Loss
NetIncomeLoss
85796000 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
36622000 USD
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-2100000 USD
CY2012Q3 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-700000 USD
CY2011Q4 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-800000 USD
us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-1900000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13943000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11872000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36060000 USD
CY2011Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3916000 USD
CY2012Q3 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
66600000 USD
CY2011Q4 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
131800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
129387000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
116985000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
43218000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
36135000 USD
CY2012Q1 us-gaap Other Assets Current
OtherAssetsCurrent
89857000 USD
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
113627000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
47734000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41075000 USD
CY2008Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease
5400000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
3868000 USD
CY2011Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-42134000 USD
CY2012Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
20446000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
22317000 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
20764000 USD
CY2011Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-41910000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
4806000 USD
CY2012Q3 us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-299000 USD
us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-897000 USD
CY2011Q4 us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-299000 USD
us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-897000 USD
CY2012Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
19000 USD
CY2011Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-75000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-57000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
434394000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
469835000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2719000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-586000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2358000 USD
CY2011Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-16000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
110004000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2092000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
416000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23913000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
23875000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24350000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24979000 USD
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
580000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
291000000 USD
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-143000 USD
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-2303000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
456000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23670000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22944000 USD
CY2011Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8797000 USD
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10412000 USD
CY2011Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8250000 USD
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10759000 USD
CY2012Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10625000 USD
CY2011Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
9057000 USD
us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
23000 USD
us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
98000 USD
CY2012Q3 us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
154000 USD
CY2011Q4 us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
-255000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11025000 USD
CY2011Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3863000 USD
CY2012Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4304000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
13344000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
922000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
708000 USD
CY2012Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
221000 USD
CY2011Q4 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
365000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
10552000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
12960000 USD
CY2012Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4063000 USD
CY2011Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3493000 USD
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
501327000 USD
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
451953000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
201648000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
174567000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
333000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
496000000 USD
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30102000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
84319000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32408000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
99101000 USD
CY2011Q4 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2012Q3 us-gaap Restructuring Charges
RestructuringCharges
9672000 USD
us-gaap Restructuring Charges
RestructuringCharges
3340000 USD
us-gaap Restructuring Charges
RestructuringCharges
21034000 USD
CY2012Q3 us-gaap Restructuring Reserve
RestructuringReserve
21161000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
13958000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1510683000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1572385000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
934333000 USD
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
301788000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1070504000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
349067000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1542284000 USD
CY2011Q4 us-gaap Sales Revenue Net
SalesRevenueNet
452935000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1379178000 USD
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
509604000 USD
CY2012Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
160537000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
471780000 USD
CY2011Q4 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
151147000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
444845000 USD
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
10000000 shares
CY2012Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
6000000 shares
CY2012Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
145442000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
404217000 USD
CY2011Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
133119000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
452026000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9427000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
15352000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.011
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.387
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.381
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3110000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
2.9 years
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
19.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
210000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
22.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
14000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
22.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
756000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.28
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25800000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4707000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5346000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.65
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.57
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
25200000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4518000 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
21.55
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
3.8 years
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
21400000 USD
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
3.9 years
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1171000 shares
CY2010Q3 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
15000000 shares
CY2012Q3 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
6000000 shares
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
1842216000 USD
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
1942440000 USD
CY2012Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
50000000 USD
CY2012Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
43000000 USD
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114998000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114063000 shares
CY2011Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113425000 shares
pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
-12459000 USD
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
6750000 USD
pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
311269000 USD
pki Percentage Of Business Outside Domestic Country
PercentageOfBusinessOutsideDomesticCountry
0.60
pki Repatriated Foreign Earnings
RepatriatedForeignEarnings
229200000 USD
pki Repurchased Common Shares For Statutory Tax Withholding Obligations
RepurchasedCommonSharesForStatutoryTaxWithholdingObligations
81776 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114565000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113065000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113491000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113860000 shares
CY2011Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
112703000 shares
pki Accrued Expenses And Other
AccruedExpensesAndOther
-1884000 USD
pki Accrued Expenses And Other
AccruedExpensesAndOther
-79725000 USD
CY2012Q3 pki Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectTax
2100000 USD
pki Aggregate Cost Of Repurchased Common Shares For Statutory Tax Withholding Obligations
AggregateCostOfRepurchasedCommonSharesForStatutoryTaxWithholdingObligations
2100000 USD
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
432000 USD
pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
4774000 USD
CY2012 pki Change In Any One Of Input Assumptions For Various Reporting Units
ChangeInAnyOneOfInputAssumptionsForVariousReportingUnits
0.100
pki Duration Of Foreign Currency Derivatives
DurationOfForeignCurrencyDerivatives
30 days
CY2012Q3 pki Forward Foreign Exchange Contracts With Euro Equivalent Notional Amounts
ForwardForeignExchangeContractsWithEuroEquivalentNotionalAmounts
125000000 EUR
pki Gains On Step Acquisitions And Dispositions Net
GainsOnStepAcquisitionsAndDispositionsNet
0 USD
pki Gains On Step Acquisitions And Dispositions Net
GainsOnStepAcquisitionsAndDispositionsNet
-200000 USD
CY2012Q1 pki Increase Decrease In Accrued Tax Provision Related To Repatriation Of Unremitted Foreign Earnings
IncreaseDecreaseInAccruedTaxProvisionRelatedToRepatriationOfUnremittedForeignEarnings
79700000 USD
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
827000 shares
CY2012Q3 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
830000 shares
CY2011Q4 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
566000 shares
pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
861000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
137000 shares
pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
247000 shares
CY2012Q3 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
308000 shares
CY2011Q4 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
156000 shares
CY2012Q3 pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-700000 USD
CY2011Q4 pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-800000 USD
pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-2100000 USD
pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-1900000 USD
CY2008Q2 pki Notional Amount Of Interest Rate Derivatives Settled
NotionalAmountOfInterestRateDerivativesSettled
150000000 USD
pki Number Of Former Stock Based Compensation Plans
NumberOfFormerStockBasedCompensationPlans
1
CY2012 pki Number Of Years In Measurement Period From Acquisition Date To Change Underlying Assumptions
NumberOfYearsInMeasurementPeriodFromAcquisitionDateToChangeUnderlyingAssumptions
1 years
pki Number Of Years Over Which Estimated Environmental Cost Will Be Paid
NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid
10 years
pki Open Tax Years By Major Tax Jurisdiction Begin Date
OpenTaxYearsByMajorTaxJurisdictionBeginDate
2003
pki Open Tax Years By Major Tax Jurisdiction End Date
OpenTaxYearsByMajorTaxJurisdictionEndDate
2011
pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
-137000 USD
CY2010Q3 pki Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased
5000000 shares
CY2012Q3 pki Unrecognized Tax Benefits Expected To Be Resolved With In Year
UnrecognizedTaxBenefitsExpectedToBeResolvedWithInYear
9500000 USD
CY2012 pki Unremitted Earnings Planned To Be Repatriated
UnremittedEarningsPlannedToBeRepatriated
350000000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000031791
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
114780142 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
PERKINELMER INC
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes

Files In Submission

Name View Source Status
0001445305-12-003461-index-headers.html Edgar Link pending
0001445305-12-003461-index.html Edgar Link pending
0001445305-12-003461.txt Edgar Link pending
0001445305-12-003461-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
pki-20120930.xml Edgar Link completed
pki-20120930.xsd Edgar Link pending
pki-20120930_cal.xml Edgar Link unprocessable
pki-20120930_def.xml Edgar Link unprocessable
pki-20120930_lab.xml Edgar Link unprocessable
pki-20120930_pre.xml Edgar Link unprocessable
pki-9302012x10q.htm Edgar Link pending
pki-9302012xex_311.htm Edgar Link pending
pki-9302012xex_312.htm Edgar Link pending
pki-9302012xex_321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending